{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:10:31Z","timestamp":1792714231393,"version":"4.5.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149411","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T18:52:38Z","timestamp":1456512758000},"page":"e0149411","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":95,"title":["B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine\/Chemokines Are Elevated in MOG Antibody Associated Demyelination"],"prefix":"10.1371","volume":"11","author":[{"given":"Kavitha","family":"Kothur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Wienholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M","family":"Tantsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Earl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Bandodkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Prelog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Tea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Brilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"issue":"14","key":"ref1","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1021\/jm010811t","article-title":"Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis","volume":"44","author":"A Carotenuto","year":"2001","journal-title":"Journal of medicinal chemistry"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1212\/NXI.0000000000000012","article-title":"Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton","volume":"1","author":"RC Dale","year":"2014","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"M Reindl","year":"2013","journal-title":"Nature reviews Neurology"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"F Brilot","year":"2009","journal-title":"Annals of neurology"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"J Kitley","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"DK Sato","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"S Ramanathan","year":"2014","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"R Hoftberger","year":"2015","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"AK Probstel","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","article-title":"Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis","volume":"69","author":"K Rostasy","year":"2012","journal-title":"Archives of neurology"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Y Hacohen","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"ref12","article-title":"Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort","author":"IA Ketelslegers","year":"2015","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1523\/JNEUROSCI.23-13-05461.2003","article-title":"Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology","volume":"23","author":"CB Marta","year":"2003","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"S Mader","year":"2011","journal-title":"Journal of neuroinflammation"},{"issue":"2","key":"ref15","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"143","author":"SJ Piddlesden","year":"1993","journal-title":"The American journal of pathology"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1756285611433772","article-title":"Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more","volume":"5","author":"MC Mayer","year":"2012","journal-title":"Therapeutic advances in neurological disorders"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"S Jarius","year":"2014","journal-title":"Clinical and experimental immunology"},{"issue":"Pt 7","key":"ref18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"CF Lucchinetti","year":"2002","journal-title":"Brain: a journal of neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12118","article-title":"Immunology of neuromyelitis optica: a T cell-B cell collaboration","volume":"1283","author":"M Mitsdoerffer","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"A Uzawa","year":"2010","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"key":"ref21","article-title":"Roitt's Essential Immunology","author":"J. Peter Delves","year":"2011"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases","volume":"127","author":"M Akdis","year":"2011","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"A Zlotnik","year":"2012","journal-title":"Immunity"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"LB Krupp","year":"2013","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"M Baumann","year":"2015","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"CL Langrish","year":"2005","journal-title":"The Journal of experimental medicine"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/intimm\/12.9.1285","article-title":"Activation-dependent modulation of B lymphocyte migration to chemokines","volume":"12","author":"M Brandes","year":"2000","journal-title":"International immunology"},{"issue":"1\u20132","key":"ref28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2008.04.025","article-title":"Lymphoid chemokines in chronic neuroinflammation","volume":"198","author":"F Aloisi","year":"2008","journal-title":"Journal of neuroimmunology"},{"issue":"6669","key":"ref29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/35876","article-title":"A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1","volume":"391","author":"MD Gunn","year":"1998","journal-title":"Nature"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.4049\/jimmunol.1002828","article-title":"CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses","volume":"186","author":"N Chevalier","year":"2011","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0165-5728(02)00441-1","article-title":"Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation","volume":"135","author":"M Pashenkov","year":"2003","journal-title":"Journal of neuroimmunology"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"B Serafini","year":"2004","journal-title":"Brain pathology"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation","volume":"17","author":"P Schneider","year":"2005","journal-title":"Current opinion in immunology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.181.1.186","article-title":"B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones","volume":"181","author":"R Takagi","year":"2008","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"ref35","article-title":"Investigations on CXCL13 in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Potential Biomarker of Treatment Response","author":"F Leypoldt","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"ref36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2013.01.011","article-title":"Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders","volume":"326","author":"MR Pranzatelli","year":"2013","journal-title":"Journal of the neurological sciences"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"MC Kowarik","year":"2012","journal-title":"Journal of neuroinflammation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.10.001","article-title":"Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica","volume":"240\u2013241","author":"X Zhong","year":"2011","journal-title":"Journal of neuroimmunology"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"M Khademi","year":"2011","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.10.002","article-title":"Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis","volume":"289","author":"P Horellou","year":"2015","journal-title":"Journal of neuroimmunology"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"MF Neurath","year":"2011","journal-title":"Cytokine & growth factor reviews"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2003-41281","article-title":"Interleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis","volume":"34","author":"RC Dale","year":"2003","journal-title":"Neuropediatrics"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"F Fossiez","year":"1996","journal-title":"The Journal of experimental medicine"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood.V98.12.3309","article-title":"Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice","volume":"98","author":"SB Forlow","year":"2001","journal-title":"Blood"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"R de Waal Malefyt","year":"1991","journal-title":"The Journal of experimental medicine"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","article-title":"Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice","volume":"116","author":"E Bettelli","year":"2006","journal-title":"The Journal of clinical investigation"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"e49715","DOI":"10.1371\/journal.pone.0049715","article-title":"Th17 effector cells support B cell responses outside of germinal centres","volume":"7","author":"A Patakas","year":"2012","journal-title":"PloS one"},{"issue":"32","key":"ref48","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"M Mitsdoerffer","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2013.07.019","article-title":"Post-acute serum eosinophil and neutrophil-associated cytokine\/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms\u2014a pilot study","volume":"64","author":"BD Michael","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"A Uzawa","year":"2014","journal-title":"Brain pathology"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/s10165-012-0715-9","article-title":"Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab","volume":"23","author":"M Araki","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaneurol.2013.3071","article-title":"A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder","volume":"70","author":"SH Kim","year":"2013","journal-title":"JAMA Neurol"},{"key":"ref53","article-title":"Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange","author":"H Abboud","year":"2015","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T01:37:18Z","timestamp":1567647438000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149411"}},"subtitle":[],"editor":[{"given":"Edgar","family":"Meinl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149411","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]}}}